TipRanks
Go Ultimate55% OFF

Chris Francis Insider Profile

4 Followers

Chris Francis, SVP, Corporate Development, Head of Emerging Areas at Wave Life Sciences, holds 61.87K shares in Wave Life Sciences (Ticker: WVE).

Chris Francis's Trading History

WVE
Wave Life Sciences
Feb 27, 2026SVP, Corporate Development, Head of Emerging AreasUninformative Buy141.92K$222.10K
WVE
Insider Shares: 61.87K (0.03%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 27, 2026Uninformative Sell$499.52K33,194$15.04―
Feb 27, 2026Uninformative Buy$141.92K33,194$4.27―
Feb 11, 2026Informative Sell$25.33K1,883$13.45+72.90%
Feb 11, 2026Uninformative Buy$0.0038,750$0.00―
Jan 06, 2026Uninformative Sell$150.26K9,375$16.02―

You May Also Like

Chris Francis insider profile FAQ

What is the percentage of profitable transactions made by Chris Francis?
The percentage of profitable transactions made by Chris Francis is 67%.
What is the average return per transaction made by Chris Francis?
The average return per transaction made by Chris Francis is 10.70%.
What stocks does Chris Francis hold?
Chris Francis holds: WVE stocks.
What was Chris Francis’s latest transaction?
Chris Francis’s latest transaction was an Uninformative Buy of $141.92K.
What was Chris Francis's most profitable transaction?
Chris Francis’s most profitable transaction was an Informative Sell of WVE stock on February 11, 2026. The return on the trade was 72.90%.
What is Chris Francis's role in Wave Life Sciences?
Chris Francis's role in Wave Life Sciences is SVP, Corporate Development, Head of Emerging Areas.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.